ColonX
Natural health product licensed in Canada
- Other names
- Cleanse FX, Colon Support, Gut Help, Met Colon
- Licence holder
- Xymogen
- NPN or DIN-HM
- 80071466
- Status
- Active licence
- Licence date
- 27 July 2016
- Revision date
- 19 December 2017
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Aloe ferox Mill.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans, aux femmes enceintes et allaitantes et une mention déconseillant l'usage prolongé
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Magnésium Source : Citrate de magnésium | 100 milligramme | Not calculated |
| Aloe ferox Source : Latex | 25 milligramme | Not calculated |
| Emblica officinalis Source : Fruit Extraction ratio : 15:1 Dry plant equivalent : 625.5 milligramme | 41.7 milligramme | Not calculated |
| Terminalia bellirica Source : Fruit Extraction ratio : 15:1 Dry plant equivalent : 625.5 milligramme | 41.7 milligramme | Not calculated |
| Terminalia chebula Source : Fruit Extraction ratio : 15:1 Dry plant equivalent : 625.5 milligramme | 41.7 milligramme | Not calculated |
Non-medicinal ingredients
Acide stéarique, Hypromellose, Dioxyde de silicium, Stéarate de magnésium, Triglycérides à chaîne moyenne
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | minimum: 2 weeks ; maximum: 3 weeks |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to maintain proper muscle function; stimulant laxative; short-term relief of occasional constipation; promotes bowel movement (by direct action on the large intestine).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80071466
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2017. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.